Bronchoscopic aspects of renal cell carcinoma (RCC)

被引:0
|
作者
Dobbertin, I
Dierkesmann, R
Kwiatkowski, J
Reichardt, W
机构
[1] Klin Pneumol & Thoraxchirurg, Klin Schillerhohe, D-70839 Gerlingen, Germany
[2] Klin Pneumol & Thoraxchirurg, Klin Schillerhohe, D-70839 Gerlingen, Germany
[3] Katharinenhosp, Radiol Klin, D-70174 Stuttgart, Germany
关键词
renal cell carcinoma; bronchoscopic tumor treatment; endobronchial brachytherapy; angiography of bronchial artery; haemoptysis; metastatic bronchopulmonay tumors;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A symposium on RCC in July 1998 in Tubingen was where we to reviewed our patients with endobronchial metastatic RCC treated by bronchoscopy since 1981. 24 of 26 consecutive cases are the subject of the present study. Tumor history, X-ray findings, endobronchial appearance, treatment and the pathogenetic mechanisms of this special form of metastatic spread are demonstrated and discussed. In 5 patients > 10 years relapsed between nephrectomy and bronchoscopic tumor therapy. A thrombuslike tumor growth and bleeding were striking bronchoscopic features. In X-my besides atelectasis, hilar or mediastinal masses were seen half of the patients, in 50% without parenchymal lung nodes, suggesting lymphogenic spread In several patients bronchial recanalisation could be successfully repeated over long periods. Abnormal X-ray, haemoptysis or dyspnoa in patients with RCC demands bronchoscopy. In case of bronchial tumor obstruction bronchoscopic treatment offers excellent palliation.
引用
收藏
页码:1567 / 1572
页数:6
相关论文
共 50 条
  • [41] Association of renal cell carcinoma (RCC) and hematological malignancy (HM)
    Varella, L.
    Chintapatla, R.
    Wiernik, P. H.
    Dutcher, J.
    BJU INTERNATIONAL, 2012, 110 : 10 - 11
  • [42] mTOR Pathway Alterations in Chromophobe Renal Cell Carcinoma (RCC)
    Albadine, R.
    Schultz, I.
    Demarza, A. M.
    Argani, P.
    Carducci, M.
    Pili, R.
    Netto, G. J.
    MODERN PATHOLOGY, 2010, 23 : 174A - 174A
  • [44] Combination targeted therapy in advanced renal cell carcinoma (RCC)
    Sosman, J.
    Puzanov, I.
    Atkins, M.
    Flaherty, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 16 - 16
  • [45] Oncocytic renal cell carcinoma (RCC) following neuroblastoma.
    Medeiros, LJ
    Palmedo, G
    Krigman, HR
    Kovacs, G
    Beckwith, JB
    LABORATORY INVESTIGATION, 1999, 79 (01) : 101A - 101A
  • [46] Development of renal cell carcinoma (RCC) diagnostics and impact on prognosis
    Sunela, Kaisa L.
    Lehtinen, Eero T.
    Kataja, Matti J.
    Kujala, Paula M.
    Soimakallio, Seppo
    Kellokumpu-Lehtinen, Pirkko-Liisa I.
    BJU INTERNATIONAL, 2014, 113 (02) : 228 - 235
  • [47] SERUM BIOMARKERS IN METASTATIC RENAL-CELL CARCINOMA (RCC)
    DEXEUS, F
    LOGOTHETIS, C
    CHONG, C
    SELLA, A
    LIU, F
    FITZ, K
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 178 - 178
  • [48] Current treatment in advanced renal cell carcinoma (RCC): Impact of targeted therapies in the management of RCC
    Bellmunt, Joaquim
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (07) : 484 - 491
  • [49] Expression of MAP kinase and Akt in clear renal cell carcinoma (RCC), including sarcomatoid RCC
    Tamboli, P
    Mathew, P
    Bekele, BN
    Prieto, VG
    LABORATORY INVESTIGATION, 2005, 85 : 166A - 166A
  • [50] Transcriptomic and metabolomic profiles in renal cell carcinoma (RCC) tumors reflect ontogeny of RCC subtypes
    Fisel, Pascale
    Buettner, Florian
    Reustle, Anna
    Klumpp, Verena
    Winter, Stefan
    Rausch, Steffen
    Hennenlotter, Joerg
    Kruck, Stephan
    Stenzl, Arnulf
    Wahrheit, Judith
    Sonntag, Denise
    Scharpf, Marcus
    Fend, Falko
    Agaimy, Abbas
    Hartmann, Arndt
    Bedke, Jens
    Schwab, Matthias
    Schaeffeler, Elke
    CANCER RESEARCH, 2018, 78 (13)